+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
COLINZ COLINZ

Colinz Laboratories Share Price

₹80.00 +0 (0%)
121.55% Gain from 52W Low

19 Aug, 2026 3:24 PM (IST)

Colinz Laboratories live price: ₹80.00. It opened at ₹76 vs previous close ₹80; intraday high/low: ₹84/₹76. The 50 & 200 DMA stand at ₹73.90/₹59.30.

Colinz Laboratories Performance

  • Today's Low
  • ₹76
  • Today's High
  • ₹84
  • 52 Week Low
  • ₹36
  • 52 Week High
  • ₹88
  • Open Price₹76
  • Previous Close₹80
  • Volume3,487
  • 50 DMA₹73.90
  • 100 DMA₹66.20
  • 200 DMA₹59.30

Colinz Laboratories Chart

Investment Returns

  • Over 1 Month + 2.51%
  • Over 3 Month + 77.54%
  • Over 6 Month + 52.15%
  • Over 1 Year + 85.74%

Smart Investing Starts Here Start SIP with Colinz Laboratories for Steady Growth!

Invest Now

Colinz Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 7.2
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 20
  • P/B Ratio
  • 2
  • Average True Range
  • 5.1
  • EPS
  • 11.1
  • Dividend Yield
  • 0
  • MACD Signal
  • 1.8
  • RSI
  • 52.53
  • MFI
  • 36.38

Latest Stock News Updates

Colinz Laboratories Ltd - 531210 - Updates on Open Offer

Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Reminder Advertisement dated August 11, 2026 in relation to the open offer of Colinz Laboratories Ltd ("Target Company").

Colinz Laboratories Ltd - 531210 - Updates on Open Offer

Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of offer opening public announcement under Regulation 18(7) of the SEBI (SAST) Regulations, 2011, as amended and and corrigendum to the detailed public statement with respect to the Open Offer, for the attention of the Public Shareholders of Colinz Laboratories Ltd ("Target Company").

Colinz Laboratories Ltd - 531210 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Dear Sir, Submitting herewith the News Paper Clipping towards Advertiement in Newspaper towards submission of Declaration of Independent Directors Under SEBI SAST Regulation ,2011 and Regulation 26(7) towards News Paper Publication published on 05-08-2026. Kindly take the same on Records. For Colinz Labs Ltd B B Dias Director

Colinz Laboratories Financials

Colinz Laboratories Technicals

EMA & SMA

Current Price
₹80.00
0 (0%)
pointer
  • Bearish Moving Average 6
  • Bullish Moving Average 10
  • 20 Day
  • ₹79.80
  • 50 Day
  • ₹73.90
  • 100 Day
  • ₹66.20
  • 200 Day
  • ₹59.30

Resistance and Support

80 Pivot Speed
  • R3 85.90
  • R2 83.50
  • R1 81.70
  • S1 77.60
  • S2 75.30
  • S3 73.50

Colinz Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-07-30 Quarterly Results
2026-04-29 Quarterly Results
2026-01-24 Quarterly Results
2026-01-17 Others
2025-11-27 Others Inter-alia to approve appointment of Ms. Falguni Kumawat as the Company Secretary and Compliance Officer of the Company and Key Managerial Personnel of the Company.

Colinz Laboratories Shareholding Pattern

50.6%
49.39%
0%

About Colinz Laboratories

Colinz Laboratories is engaged in the manufacturing and marketing of pharmaceutical formulations particularly in gynaecological sector. View More
  • NSE Symbol
  • COLINZ
  • BSE Symbol
  • 531210
  • ISIN
  • INE923C01011

Similar Stocks to Colinz Laboratories

Colinz Laboratories FAQs

Colinz Laboratories share price is ₹80 As on 19 August, 2026 | 16:36

The Market Cap of Colinz Laboratories is ₹20.2 Cr As on 19 August, 2026 | 16:36

The P/E ratio of Colinz Laboratories is 7.2 As on 19 August, 2026 | 16:36

The PB ratio of Colinz Laboratories is 2 As on 19 August, 2026 | 16:36

The 52 week High & Low of Colinz Laboratories is ₹87.9/₹36.1 respectively As on 19 August, 2026 | 16:36

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23